Dhaval Patel leads UCB’s research organization with the main goal of bringing scientific innovation to patients and helping them live the life they choose.

Dhaval Patel is a medical doctor and holds a PhD in Microbiology and Immunology. He comes to UCB from Novartis, based in their headquarters in Basel, Switzerland, where for 11 years he led various biomedical research teams in areas of neurology, autoimmunity, transplantation and inflammation. In 2010, he became the Head of Research for the Novartis Institutes for BioMedical Research (NIBR) Europe.

For 12 years prior to crossing into industry, Dhaval made a strong mark in the halls of academia and research, specifically at Duke University Medical Center and the University of North Carolina (UNC) at Chapel Hill in North Carolina in the US. He authored and co-authored over 100 thought-leading publications and presentations.

He is a member of UCB’s Executive Committee.

Key positions Prior to UCB, Dhaval held the following positions:

2006 – 2017 Novartis International AG Head of Research of the Novartis Institutes for BioMedical Research Europe Global Head of Autoimmunity, Transplantation and Inflammation at the Novartis Institutes for BioMedical Research

2003 – 2006 University of North Carolina at Chapel Hill, USA Director, Thurston Arthritis Research Center Chief of the Rheumatology, Allergy and Immunology division Professorships in the Department of Medicine, Microbiology and Immunology

1994 – 2003 Duke University Medical Center, USA Chief of the Allergy and Immunology division Professorships in the Department of Medicine and Immunology EducationDhaval Patel graduated from Duke University where he completed a Bachelor in Science degree, an MD and a PhD in Microbiology and Immunology